Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

683 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Accurate prediction of neuroblastoma outcome based on miRNA expression profiles.
Schulte JH, Schowe B, Mestdagh P, Kaderali L, Kalaghatgi P, Schlierf S, Vermeulen J, Brockmeyer B, Pajtler K, Thor T, de Preter K, Speleman F, Morik K, Eggert A, Vandesompele J, Schramm A. Schulte JH, et al. Among authors: schramm a. Int J Cancer. 2010 Nov 15;127(10):2374-85. doi: 10.1002/ijc.25436. Int J Cancer. 2010. PMID: 20473924
Proteomics: techniques and applications in cancer research.
Schramm A, Apostolov O, Sitek B, Pfeiffer K, Stühler K, Meyer HE, Havers W, Eggert A. Schramm A, et al. Klin Padiatr. 2003 Nov-Dec;215(6):293-7. doi: 10.1055/s-2003-45502. Klin Padiatr. 2003. PMID: 14677091
Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas.
Schulte JH, Schramm A, Klein-Hitpass L, Klenk M, Wessels H, Hauffa BP, Eils J, Eils R, Brodeur GM, Schweigerer L, Havers W, Eggert A. Schulte JH, et al. Among authors: schramm a. Oncogene. 2005 Jan 6;24(1):165-77. doi: 10.1038/sj.onc.1208000. Oncogene. 2005. PMID: 15637590
Biological effects of TrkA and TrkB receptor signaling in neuroblastoma.
Schramm A, Schulte JH, Astrahantseff K, Apostolov O, Limpt Vv, Sieverts H, Kuhfittig-Kulle S, Pfeiffer P, Versteeg R, Eggert A. Schramm A, et al. Cancer Lett. 2005 Oct 18;228(1-2):143-53. doi: 10.1016/j.canlet.2005.02.051. Cancer Lett. 2005. PMID: 15921851 Review.
Application of microarray-based technology to neuroblastoma.
Scaruffi P, Valent A, Schramm A, Astrahantseff K, Eggert A, Tonini GP. Scaruffi P, et al. Among authors: schramm a. Cancer Lett. 2005 Oct 18;228(1-2):13-20. doi: 10.1016/j.canlet.2005.01.052. Cancer Lett. 2005. PMID: 15951106 Review.
Phox2B mutations and the Delta-Notch pathway in neuroblastoma.
van Limpt V, Chan A, Schramm A, Eggert A, Versteeg R. van Limpt V, et al. Among authors: schramm a. Cancer Lett. 2005 Oct 18;228(1-2):59-63. doi: 10.1016/j.canlet.2005.02.050. Cancer Lett. 2005. PMID: 16084642 Review.
683 results